Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Severe enterovirus disease in febrile neonates
Información de la revista
Vol. 27. Núm. 7.
Páginas 399-402 (Agosto 2009)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 27. Núm. 7.
Páginas 399-402 (Agosto 2009)
DOI: 10.1016/j.eimc.2008.06.008
Acceso a texto completo
Severe enterovirus disease in febrile neonates
Enfermedad grave por enterovirus en el neonato con síndrome febril
Visitas
...
Iolanda Jordána, Cristina Estevab, Elisabeth Estebana, Antoni Noguerac, Juan-José Garcíac, Carmen Muñoz-Almagrob
a Pediatrics Intensive care Unit, University Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain
b Molecular Microbiology Department, Microbiology Service, University Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain
c Pediatrics Department, University Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Introduction

Fever in newborn infants may be due to an invasive infection with potential morbidity and mortality. Our aim was to describe the characteristics and outcome of group of febrile neonates with severe enterovirus infection compared to a group of neonates with severe bacterial infection.

Introducción

En el recién nacido, el síndrome febril puede obedecer a una infección invasiva, que puede conllevar una elevada morbi-mortalidad. Nuestro objetivo fue describir las características y evolución clínica de un grupo de neonatos con fiebre sin foco debida a infección grave por enterovirus, en comparación con otro grupo de neonatos con infección bacteriana grave.

Patients and methods

Prospective study including all neonates (<29 days old) admitted to a teaching hospital for fever (>38°C), with positive bacterial cultures or enterovirus detection in sterile samples, from September 2003 to December 2004. Clinical information, analytical data at admission (complete leukocyte count and C-reactive protein concentrations), blood, urine, and cerebrospinal fluid culture results, molecular detection of enterovirus by polymerase chain reaction (PCR), and outcome were recorded.

Pacientes y métodos

Estudio prospectivo de todos los recién nacidos (edad<de 29 días de vida) admitidos en un Hospital universitario por fiebre (>38°C) y cultivo bacteriano positivo o detección de enterovirus en muestras estériles, desde septiembre de 2003 a diciembre 2004. Se recogieron datos clínicos y analíticos (recuento leucocitario y proteína C reactiva) en el momento del ingreso, hemocultivo, urinocultivo y cultivo de líquido cefalorraquídeo, detección molecular de enterovirus mediante reacción en cadena de la polimerasa (PCR) y evolución final.

Resultados

Se recogieron 62 pacientes con infección bacteriana grave: infección del tracto urinario (n=57, incluyendo 8 casos con bacteriemia), sepsis (n=3), meningitis (n=2). La PCR para enterovirus fue positiva en 10 pacientes. La proteína C reactiva fue significativamente más elevada en los niños con infección bacteriana que en los casos de infección por enterovirus (62,3 versus 9mg/L, p=0,008). Dos pacientes, uno con meningitis por Streptococcus agalactiae y otro con sepsis por S aureus, y tres pacientes con infección por enterovirus (manifestadas como miocarditis, hepatitis y meningoencefalitis) requirieron ingreso en la unidad de cuidados intensivos pediátrica. De estos, el recién nacido con infección por S agalactiae y dos de los 3 pacientes con infección por enterovirus fueron exitus.

Results

Invasive bacterial infections were observed in 62 patients: urinary tract infection (n=57, including 8 cases of bacteremia), sepsis (n=3), and meningitis (n=2). Molecular tests for enterovirus were positive in 10 patients. C-reactive protein values were significantly higher in neonates with bacterial infection than in those with enterovirus infection (62,3 versus 9mg/L, P=0,008). Two patients with Streptococcus agalactiae meningitis, 1 with Staphylococcus aureus sepsis and 3 with enterovirus infection (manifested as myocarditis, hepatitis, and meningoencephalitis) required admission to the pediatric intensive care unit. Among these, 1 newborn with S. agalactiae and 2 of the 3 with enterovirus infection died.

Conclusiones

En nuestra serie, la infección por enterovirus fue una causa importante de enfermedad grave. El diagnóstico viral específico podría contribuir al manejo del neonato febril.

Conclusions

In our series, enterovirus infection was an important cause of severe invasive disease. Specific viral diagnosis can contribute to the management of febrile neonates.

Palabras clave:
Enterovirus
Recién nacido
Fiebre
Infección bacteriana
Texto completo
Introduction

Fever is the main symptom of infection and sometimes the only clinical manifestation of a serious infectious disease, particularly in newborns. Approximately 10% of fevers in children under the age of 90 days are due to potentially harmful bacterial infections.1 Differentiating patients with serious febrile illnesses from those who suffer more benign infectious processes has always been a challenge for pediatricians, and has resulted in aggressive approaches to fever management at these early ages. The usual diagnostic and therapeutic approach to a neonate with fever includes hospitalization, collection of blood urine, and cerebrospinal fluid (CSF) for bacterial culture, and empirical parenteral antibiotic treatment.2 Additional microbiological analyses are performed depending on the clinical suspicion at admission and later evolution. The combination of anamnestic data, clinical examination, and laboratory findings can sometimes help to identify infants at a high risk for a life-threatening bacterial infection. Medical advances in the prevention and control of neonatal bacterial infections have been extensively reported, whereas less is known about the medical management of viral infections.3

Enterovirus infection is a significant cause of fever in young infants4,5,6,7 and shows a mild and self–limited clinical course in most cases. Nonetheless, serious enterovirus infections leading to hepatitis, myocarditis or septicemia have been reported.8,9,10 Molecular detection of enterovirus by polymerase chain reaction (PCR) techniques may provide an early etiologic diagnosis in febrile infants and facilitate the initial management of these patients.

In this study, we describe the characteristics and outcome of enterovirus infections and compare them to those of classical bacterial infections in a series of febrile neonates attended at a pediatric emergency department.

Patients and methods

A prospective observational study was performed in a series of neonates (<29 days of age) admitted for fever of unknown source to Sant Joan de Déu University Hospital from September 2003 to December 2004. Sant Joan de Déu, located in the metropolitan area of Barcelona (Spain), is a 345-bed public health community hospital for children and is a referral centre for the geographic area of Barcelona.

Our hospital guidelines contain a diagnosis and treatment protocol to evaluate neonates with fever (rectal temperature above 38°C) of unknown source. It includes complete blood analysis, and culture of urine, blood and CSF. Parenteral antibiotic treatment is then initiated in all these patients at admission. Enterovirus is not a routine determination and is only analyzed when cultures are negative or there is no response at 24–48hours after starting antibiotics.

Newborns who met the following criteria were enrolled in the study: younger than 29 days, fever of unknown source, admitted to the emergency department, and confirmed diagnosis of bacterial or enterovirus infection. The exclusion criterion was nosocomial bacterial infection. The study was approved by the hospital Ethics Committee.

Medical data from eligible newborns included the following information: age and sex, results of the clinical examination at admission, vital signs, past medical history, clinical evolution, and final outcome. Results of total white blood cell count (WBC), with differential cell count, C-reactive protein (CRP) levels (CRP; Architect Analyzer, Abbott Diagnostics, Abbott Park, Illinois, USA), bacterial culture in urine, CSF and blood, and enterovirus detection by specific pan-enterovirus PCR (Light Diagnostics Pan-Enterovirus Oligodetect® Chemicon, California USA) were also included. For total WBC, cell count, and CRP levels, the analysis was performed with the results from the first sample, taken at the emergency department.

Statistical analysis

Patients with bacterial infection or a positive enterovirus PCR were included in the statistical analyses (performed with SPSS®, version 12.1). Differences for discrete variables were estimated with the Fisher exact test. Quantitative variables were compared using the Student t test. P values <0.05 were considered statistically significant.

Results

During the study period, 328 febrile neonates enrolled in the study presented fever without an apparent source. The age range was 3 to 28 days, 185 were male (56.4%), and 143 (43.6%) were female. Bacterial cultures were positive in 62 patients (18.9%), yielding the following diagnoses: urinary tract infection in 49 infants (79%), with accompanying bacteremia in 8 cases (13%); sepsis in 3 patients (5%); and meningitis with bacteremia in 2 patients (3%). The most prevalent bacterial pathogen was Escherichia coli (43 cases, 69%), which accounted for most of the urinary tract infections, with or without bacteremia, whereas Streptococcus agalactiae was responsible for 4 cases of sepsis or meningitis. Two patients had cutaneus cellulitis and 2 had impetigo with negative blood culture, but positive local testing for Staphylococcus aureus. No patients were excluded because of a nosocomial bacterial infection.

Enterovirus was detected in 10 patients with a mean age of 14.8 days (range 4–27 days). Six patients (40%) were male. There were no other bacterial or viral infectious etiologies in these cases. Two patients were moderate ex-premature neonates (gestational age, 34 and 35 months).

Other viral etiologies in the overall series included influenza A virus in 6 patients, respiratory syncytial virus in 25 patients, and rotavirus infection in 3 cases. Two patients had lymphocytic meningitis, without an etiological viral diagnosis.

Serious Bacterial Infection versus Enterovirus Infection

The clinical data in the 2 patient groups (bacterial or enterovirus infection) are shown in tabla 1. Although there were no significant differences in age between the groups, 50% of patients with an enterovirus infection were newborns younger than 10 days. These younger patients presented the poorest evolution and most were admitted to the pediatric intensive care unit (PICU). C-reactive protein values were significantly higher in newborns with microbiologically confirmed bacterial infections (range 2.5–266.4mg/L, mean 62.3mg/L) than in those with enterovirus infection (range 0.4–19.2mg/L, mean 9mg/L) P=0.008. No statistically significant differences were found between the 2 groups for WBC count and band count.

Table 1. Characteristics and Clinical Outcome Data in Patients with Bacterial Infection or Enterovirus Infection

BI group (N=62)EI group (N=10)P
Age, days
Mean±SD16.36±4.914.8±8.9NS
Sex
Male27 (43.5%)6 (40%)NS
WBC
Leukocytes×10314.4±7.112.5±5.2NS
Band count (%)2.75%1.03%NS
CRP mg/L (range) mean(2.5–266.4) 62.3(0.4–19.2) 90.008
PICU admittance3 (4.8%)3 (30%)
Evolution
Good59 (95.1%)7 (70%)
Death1 (1.6%)2 (20%)
With sequelae2 (3.2%)1 (10%)

BI, Bacterial infection group; CRP, C-reactive protein; EI, Enterovirus infection group; N, Number of observed cases; NS, Non-significant; PICU, pediatric intensive care unit; WBC, white blood cell.

With regard to the clinical outcome, the PICU received 3 infants with enterovirus and 3 infants with sepsis/meningitis from the bacterial group. A poor evolution leading to death occurred in 2 infants with enterovirus infection. The first case was an infant born of a healthy, 29-year-old mother who had a mild febrile illness in the antepartum, with no other relevant clinical data. Antibiotic treatment was started from the first day of the neonate's life due to the high risk of infection. The illness had a biphasic pattern: 6 days after birth, the newborn showed mild febrile signs. Some 48hours later, the condition had progressed to severe systemic involvement with meningitis and cardiomyopathy. The results of bacterial cultures, serological analysis, and metabolic studies were negative. PCR testing for enterovirus in CSF and blood samples was positive. The newborn died on day 20 after birth.

The second case showed similar preliminary data: first pregnancy of a healthy mother with a febrile illness in the antepartum, and no other relevant data. The newborn showed symptoms of a febrile illness at 4 days after birth. Twenty-four hours later, the symptoms were consistent with a metabolic syndrome (fever, lethargy, hypotonia, and hepatitis), but metabolic studies and bacterial culture were negative. The progression was fulminant, and the patient died 8 days after birth. Liver biopsy with molecular diagnostic methods was positive for enterovirus. As to the 13 neonates with confirmed hematogenous bacterial spread, 11 (84.6%) had a good evolution, 2 (15.3%) were left with moderate disability, and there was 1 death (7.7%) in a patient with fulminant S. agalactiae sepsis.

In patients without a microbiological diagnosis and a favorable clinical and analytical outcome, we hypothesized that the cause of fever was a viral agent or a non-invasive bacterial infection. The low positive culture rates were consistent with reported rates, and are attributed to the difficulty of obtaining a blood sample above 2mL in newborns.

Discussion

Infants younger than 28 days have a greater risk of developing systemic infection compared to older infants. It is well recognized that hematogenous spread of bacterial infection is common in this age group; hence, a focal infection can progress to sepsis. A similar pattern of infectious spread can be applied to enterovirus, as has been suggested for other pathogens, such as cytomegalovirus, herpes, and other viral and bacterial infections.11

With regard to the etiology (confirmed by microbiological analysis) of neonatal fever, E. coli and S. agalactiae were the most common bacterial agents. These findings are also in keeping with the literature.12 Our patients were not affected with early bacterial sepsis, likely because of the current advances in the prevention and management of perinatal bacterial infection.

The consequences of viral infection in newborns may differ because of several risk factors,13,14 such as a background of maternal infection, gestational age of the neonate, site of the infection, and the microorganism involved. In our study, the newborns with enterovirus infection showing the poorest evolution had developed symptoms within 10 days after birth, and in all cases, the symptoms were consistent with the maternal infection prior to delivery.

Based on its clinical features, enterovirus is considered a common cause of fever and aseptic meningitis in young infants as a self-limited infection. Generalized enterovirus infection in neonates occurs in one of two characteristic clinical syndromes: myocarditis (characteristically a manifestation of group B coxsackievirus infection) and fulminant hepatitis (typically from echovirus 11 or other serotypes).15,16,17 In our study, 2 patients developed multiorgan disease with a fatal evolution. In fact, enterovirus was the primary cause of death in our neonate series, with fever as the initial symptom. Enterovirus severity is probably associated with perinatal transmission and poor immunity in this age range. In general, because the immune system is immature in extremely premature babies, they have the highest incidence of mortality and morbidity. Some authors have reported a favorable outcome of treatment with pleconaril, a new antipicornaviral agent,8,18 but this drug is not currently available. High doses of intravenous immune globulin have also been reported to improve outcome.19 Because of the potentially serious evolution of enterovirus infection in neonates, new multicenter studies should be undertaken to evaluate the treatment strategies for this condition.

Several studies have demonstrated the value of C-reactive protein analysis to evaluate children with fever and no localizing signs of infection.20,21 In our series, CRP values were significantly (P<0.01) higher in the bacterial group than in the enterovirus group. The 7-fold higher CRP values in the former were more useful than white blood cell count or band count to differentiate between bacterial and viral infection. Nevertheless, any of these blood markers are useful for detecting a severe viral infection such as enterovirus.

All cases of enterovirus infection were detected by pan-enterovirus PCR. This is a useful technique for fast, specific, sensitive diagnosis in various specimens, such as blood, CSF, and others.22,23 The use of PCR to identify febrile infants with enterovirus infection contributes positively in rational and specific management of the etiological cause of fever. Pan-enterovirus PCR is not a routine test in our hospital and is only performed in samples from febrile patients who progress poorly. This fact may mask the true prevalence of enterovirus infection in newborns. In any case, it is well recognized that enterovirus infection is very common in infants; several authors have reported incidence rates of 25% to 50% in febrile infants,24 the majority with self-limited disease. The present study underscores the fact that enterovirus infection in newborns is a risk factor for serious invasive disease and a fatal evolution. Additional studies are needed to evaluate trends over time and the role of enterovirus in infections associated with serious invasive disease and neonatal death.

Bibliography
[1]
Byington CL, Rittichier KK, Bassett KE, et-al..
Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens.
Pediatrics, 111 (2003), pp. 964-968
[2]
Baraff LJ, Bass JW, Fleisher GR, et-al..
Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research.
Ann Emerg Med, 22 (1993), pp. 1198-1210
[3]
Abzug M.J..
Presentation, diagnosis, and management of enterovirus infections in neonates.
Paediatr Drugs, 6 (2004), pp. 1-10
[4]
Khetsuriani N, Lamonte A, Oberste MS, et-al..
Neonatal enterovirus infections reported to the national enterovirus surveillance system in the United States, 1983–2003.
Pediatr Infect Dis J, 25 (2006), pp. 889-893
[5]
Dagan R..
Nonpolio enteroviruses and the febrile young infant: epidemiologic, clinical and diagnostic aspects.
Pediatr Infect Dis J, 15 (1996), pp. 67-71
[6]
Sawyer M.H..
Enterovirus infections: diagnosis and treatment.
Curr Opin Pediatr, 13 (2001), pp. 65-69
[7]
Jenista JA, Powell KR, Menegus M.A..
Epidemiology of neonatal enterovirus infection.
J Pediatr, 104 (1984), pp. 685-690
[8]
Bauer S, Gottesman G, Sirota L, et-al..
Severe Coxsackie virus B infection in preterm newborns treated with pleconaril.
Eur J Pediatr, 161 (2002), pp. 491-493
[9]
Aradottir E, Alonso EM, Shulman S.T..
Severe neonatal enteroviral hepatitis treated with pleconaril.
Pediatr Infect Dis J, 20 (2001), pp. 457-459
[10]
P Verboon-Maciolek MA, Krediet TG, Gerards LJ, et-al..
Clinical and epidemiologic characteristics of viral infections in a neonatal intensive care unit during a 12-year period.
Pediatr Infect Dis J, 24 (2005), pp. 901-904
[11]
Yang TT, Huang LM, Lu CY, et-al..
Clinical features and factors of unfavourable outcomes for non-polio enterovirus infection of the central nervous system in northern Taiwan, 1994–2003.
J Microbiol Immunol Infect, 38 (2005), pp. 417-424
[12]
Alpern ER, Alessandrini EA, Bell LM, et-al..
Occult bacteraemia from a paediatric emergency department: current prevalence, time to detection and outcome.
Pediatrics, 106 (2000), pp. 505-511
[13]
Lin TY, Kao HT, Hsieh SH, et-al..
Neonatal enterovirus infections: emphasis on risk factors of severe and fatal infections.
Pediatr Infect Dis J, 22 (2003), pp. 889-894
[14]
Cheng LL, Ng PC, Chan PK, Wong HL, Cheng FW, Tang JW. A case report of a premature infant with coxsackie B1 meningitis. Callen J, Paes BA. Adv Neonatal Care. 2007;7(5):238–4714. Probable intrafamilial transmission of coxsackievirus b3 with vertical transmission, severe early-onset neonatal hepatitis, and prolonged viral RNA shedding. Pediatrics 2006;118(3):929–33..
[15]
Modlin J.F..
Perinatal echovirus and group B coxsackievirus infections.
Clin Perinatol, 15 (1988), pp. 233-246
[16]
Reina-González G, Pérez-Ruiz M, Avellón A, Trallero G, Otero A, de la Rosa-Fraile M, et-al..
Enterovirus 75, a new pathogenic virus in Granada province (Spain).
Enferm Infecc Microbiol Clin, 25 (2007), pp. 566-569
[17]
Tseng FC, Huang HC, Chi CY, Lin TL, Liu CC, Jian JW, et-a.l, CDC-Taiwan Virology Reference Laboratories and Sentinel Physician Network..
Epidemiological survey of enterovirus infections occurring in Taiwan between 2000 and 2005: analysis of sentinel physician surveillance data.
J Med Virol, 79 (2007), pp. 1850-1860
[18]
Bryant PA, Tingay D, Dargaville PA, et-al..
Neonatal coxsackie B virus infection-a treatable disease?.
Eur J Pediatr, 163 (2004), pp. 223-228
[19]
Abzug MJ, Keyserling HL, Lee ML, et-al..
Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin.
Clin Infect Dis, 20 (1995), pp. 1201-1206
[20]
Pulliam PN, Attia MW, Cronan K.M..
C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infection.
Pediatrics, 108 (2001), pp. 1275-1279
[21]
Lacour AG, Gervaix A, Zamora SA, et-al..
Procalcitonin, IL-6, Il-8 OL-1 receptor antagonist and C reactive protein as indicators of serious bacterial infections in children with fever without localising signs.
Eur J Pediatr, 160 (2001), pp. 95-100
[22]
Fujimoto T, Shinohara M, Ito M, Okafuji T, Okafuji T, Nishio O, et-al..
Detection of dual-infected cases of adenoviruses and coxsackieviruses type B by real-time PCR but not by the conventional viral culture technique.
Clin Lab, 53 (2007), pp. 605-609
[22]
Rittichier KR, Bryan PA, Bassett KE, et-al..
Diagnosis and outcomes of enterovirus infections in young infants.
Pediatr Infect Dis J, 24 (2005), pp. 546-550
[23]
Byington CL, Taggart EW, Carroll KC, et-al..
A polymerase chain reaction-based epidemiologic investigation of the incidence of nonpolio enteroviral infections in febrile and afebrile infants 90 days and younger.
Pediatrics, 103 (1999), pp. E27
[24]
Rotbart HA, McCracken GH, Whitley RJ, et-al..
Clinical significance of enteroviruses in serious summer febrile illnesses of children.
Pediatr Infect Dis J, 18 (1999), pp. 869-874
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.